Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
MindWalk Holdings Corp.
MindWalk Holdings Corp. announced that Thomas Lynch, PhD, departed the company and ceased to serve as Chief Business Officer, effective October 16, 2026. The company stated that its commercial priorities remain unchanged and that LensAI continues to operate under existing contracted, recurring deployments.…more
MindWalk Holdings Corp.
MindWalk Holdings published a white paper demonstrating that its LensAI immunogenicity screening runs at up to 43% lower cost per sequence on Amazon EC2 Hpc8a instances powered by AMD EPYC processors. The benchmark successfully screened 890,634 antibody sequences in 4 hours and 41 minutes, which is expected to improve margins as the company scales its enterprise platform and recurring revenue.…more
MindWalk Holdings Corp.
MindWalk Holdings Corp. has strengthened its Boston-based development leadership by appointing three senior executives as its pipeline advances toward preclinical efficacy studies. These new hires, with backgrounds from companies like Pfizer and Novartis, will focus on enhancing the company's AI platform and preclinical decision-making capabilities.…more
13 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
MindWalk Holdings Q1 Earnings Miss Estimates
MindWalk Holdings reported a Q1 loss of $0.09 per share and revenue of $2.77 million, both missing analyst expectations. While revenue grew compared to the previous year, the company's losses widened, leading to a disappointing performance.…more
●●●●●●●● ●●●●● ●●●●●●
MindWalk has entered into a binding commitment for a $30 million senior unsecured revolving credit facility with Sanabil. The funds are intended to support the company's biologics programs, commercial expansion, and general corporate purposes.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.